Exosomes secreted by atorvastatin-pretreated MSCs were found to be rich in lncRNA H19, which effectively reduced cardiac dysfunction by decreasing IL-6 and TNF-α levels; thus, lncRNA H19 levels could be used as a diagnostic marker for angiogenesis and apoptosis associated with cardiac dysfunction and infarction [214]. Here, H19 is linked to infarction.